128 related articles for article (PubMed ID: 20962262)
1. Comment on "Cutting edge: FcR-like 6 is an MHC class II receptor".
Huard B
J Immunol; 2010 Nov; 185(9):4965; author reply 4965-6. PubMed ID: 20962262
[No Abstract] [Full Text] [Related]
2. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.
Johnson DB; Nixon MJ; Wang Y; Wang DY; Castellanos E; Estrada MV; Ericsson-Gonzalez PI; Cote CH; Salgado R; Sanchez V; Dean PT; Opalenik SR; Schreeder DM; Rimm DL; Kim JY; Bordeaux J; Loi S; Horn L; Sanders ME; Ferrell PB; Xu Y; Sosman JA; Davis RS; Balko JM
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568030
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.
Shapiro M; Herishanu Y; Katz BZ; Dezorella N; Sun C; Kay S; Polliack A; Avivi I; Wiestner A; Perry C
Haematologica; 2017 May; 102(5):874-882. PubMed ID: 28154084
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.
Huard B; Mastrangeli R; Prigent P; Bruniquel D; Donini S; El-Tayar N; Maigret B; Dréano M; Triebel F
Proc Natl Acad Sci U S A; 1997 May; 94(11):5744-9. PubMed ID: 9159144
[TBL] [Abstract][Full Text] [Related]
5. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
Hannier S; Triebel F
Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
[TBL] [Abstract][Full Text] [Related]
6. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.
Bruniquel D; Borie N; Hannier S; Triebel F
Immunogenetics; 1998 Jul; 48(2):116-24. PubMed ID: 9634475
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
Agrawal S; Marquet J; Freeman GJ; Tawab A; Bouteiller PL; Roth P; Bolton W; Ogg G; Boumsell L; Bensussan A
J Immunol; 1999 Feb; 162(3):1223-6. PubMed ID: 9973372
[TBL] [Abstract][Full Text] [Related]
9. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation.
Maeda M; Carpenito C; Russell RC; Dasanjh J; Veinotte LL; Ohta H; Yamamura T; Tan R; Takei F
J Immunol; 2005 Oct; 175(7):4426-32. PubMed ID: 16177084
[TBL] [Abstract][Full Text] [Related]
10. Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.
Alari-Pahissa E; Grandclément C; Jeevan-Raj B; Leclercq G; Veillette A; Held W
PLoS One; 2016; 11(4):e0153236. PubMed ID: 27054584
[TBL] [Abstract][Full Text] [Related]
11. An Unexpected Partnership: MHC Class II Molecules as Ligands for NK Cells.
Wu C; Li XC
Transplantation; 2020 Feb; 104(2):229-230. PubMed ID: 32000233
[No Abstract] [Full Text] [Related]
12. Cutting edge: FcR-like 6 is an MHC class II receptor.
Schreeder DM; Cannon JP; Wu J; Li R; Shakhmatov MA; Davis RS
J Immunol; 2010 Jul; 185(1):23-7. PubMed ID: 20519654
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the natural killer cell receptor repertoire.
Raulet DH; Vance RE; McMahon CW
Annu Rev Immunol; 2001; 19():291-330. PubMed ID: 11244039
[TBL] [Abstract][Full Text] [Related]
14. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.
Moretta A; Ciccone E; Pantaleo G; Tambussi G; Bottino C; Melioli G; Mingari MC; Moretta L
Immunol Rev; 1989 Oct; 111():145-75. PubMed ID: 2697680
[TBL] [Abstract][Full Text] [Related]
15. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.
Wang J; Sanmamed MF; Datar I; Su TT; Ji L; Sun J; Chen L; Chen Y; Zhu G; Yin W; Zheng L; Zhou T; Badri T; Yao S; Zhu S; Boto A; Sznol M; Melero I; Vignali DAA; Schalper K; Chen L
Cell; 2019 Jan; 176(1-2):334-347.e12. PubMed ID: 30580966
[TBL] [Abstract][Full Text] [Related]
17. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.
Lang P; Stolpa JC; Freiberg BA; Crawford F; Kappler J; Kupfer A; Cambier JC
Science; 2001 Feb; 291(5508):1537-40. PubMed ID: 11222857
[TBL] [Abstract][Full Text] [Related]
18. MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.
Hemon P; Jean-Louis F; Ramgolam K; Brignone C; Viguier M; Bachelez H; Triebel F; Charron D; Aoudjit F; Al-Daccak R; Michel L
J Immunol; 2011 May; 186(9):5173-83. PubMed ID: 21441454
[TBL] [Abstract][Full Text] [Related]
19. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation.
Fabriek BO; Van Haastert ES; Galea I; Polfliet MM; Döpp ED; Van Den Heuvel MM; Van Den Berg TK; De Groot CJ; Van Der Valk P; Dijkstra CD
Glia; 2005 Sep; 51(4):297-305. PubMed ID: 15846794
[TBL] [Abstract][Full Text] [Related]
20. Transport of peptide-MHC class II complexes in developing dendritic cells.
Turley SJ; Inaba K; Garrett WS; Ebersold M; Unternaehrer J; Steinman RM; Mellman I
Science; 2000 Apr; 288(5465):522-7. PubMed ID: 10775112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
